| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/29/2008 | WO2007112210A3 Optical design of a particulate measurement system |
| 05/29/2008 | WO2007105040A8 A bacterium consortium, bio-electrochemical device and a process for quick and rapid estimation of biological oxygen demand |
| 05/29/2008 | WO2006137597A9 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 05/29/2008 | WO2006100484A3 Deliver of molecules to a li id bila |
| 05/29/2008 | US20080127360 Pig cell not expressing alpha -1,3-galactosyl transferase and expressing human complement inhibitor and/or human N-acetyl glucosaminyl transferase III for use as transplantation material with dreased possibility of acute rejection |
| 05/29/2008 | US20080127358 Expression vector comprising nucleotide sequences coding cell surface signaling peptides for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080125977 Use of quantum system identification and quantum control techniques for medical diagnostic and therapeutic purposes |
| 05/29/2008 | US20080125976 Distributed sensor network with a common processing platform for cbmrne devices and novel applications |
| 05/29/2008 | US20080125975 Method for performing bioinformatics analysis program and bioinformatics analysis platform |
| 05/29/2008 | US20080125575 Thin film for use in biomedicine |
| 05/29/2008 | US20080125491 screening for neuroprotectants such as -Isobutyryl-1,4-a-dimethyl-1,2,3,4,4a,9,10,10a-octahydro-phenanthrene-1-carboxylic acid amide, used for the prevention of neurodegenerative diseases and cardiovascular disorders |
| 05/29/2008 | US20080125457 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125389 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 05/29/2008 | US20080125369 Soluble t cell receptors |
| 05/29/2008 | US20080125368 Determining angiogenin levels to aid in assessment of peritoneal membrane injury or complications of peritoneal dialysis; drug screening |
| 05/29/2008 | US20080125367 Agents for treatment of HCV and methods of use |
| 05/29/2008 | US20080125359 Antimicrobial peptides and methods of identifying the same |
| 05/29/2008 | US20080125357 Novel peptide ligand to the orphan G-protein coupled receptor ChemerinR; Prochemerin and Chemerin amino acid sequences; use in diagnosis and immunotherapy of a disease including tumors |
| 05/29/2008 | US20080124813 Using solid phase substrate comprising immobilized target capture moieties for monitoring protease and/or protease inhibitor activities |
| 05/29/2008 | US20080124812 Mixture comprising ligand immobilized solid support for isolating lysosomal enzyme components |
| 05/29/2008 | US20080124811 Monoclonal antibody specific for brain natriuretic peptide for use in diagnosis, prevention and treatment of cardiovascular disorders |
| 05/29/2008 | US20080124809 Method of Interaction Observation |
| 05/29/2008 | US20080124808 Using three dimensional hydrolase structure as tool in designing modulators of enzyme activity; rational drug design |
| 05/29/2008 | US20080124807 Protein tagging reagents |
| 05/29/2008 | US20080124789 High Throughput Functional Genomics |
| 05/29/2008 | US20080124752 Biomarkers related to metabolic age and methods using the same |
| 05/29/2008 | US20080124751 Combinatorial rosamine library and uses thereof |
| 05/29/2008 | US20080124747 Methods for detecting b. anthracis infection |
| 05/29/2008 | US20080124746 Methods and compositions relating to anthrax pathogenesis |
| 05/29/2008 | US20080124745 Method and Device for Characterizing Cellular Components of a Biological Fluid |
| 05/29/2008 | US20080124744 Antibodies That Specifically Bind PMS2 |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124742 Modulators of odorant receptors |
| 05/29/2008 | US20080124741 Canine Cholecystokinin 1 Receptor Materials And Their Use |
| 05/29/2008 | US20080124740 Crystal proteins, catalytic domains; drug screening; computer aided drug design |
| 05/29/2008 | US20080124739 Compositions and methods for the diagnosis and treatment of tumor |
| 05/29/2008 | US20080124738 Diagnosing respiratory system disorders using mycobacterium specific immunoglobulin |
| 05/29/2008 | US20080124729 Using presence of mutant microsatellite in particular chromosomal regions as diagnostic indicator for cell proliferative disorders |
| 05/29/2008 | US20080124726 Apparatus which generates single cell aqueous reaction volumes in a flow channel for use detection pf preferential protein expression in cell; high throughput assay |
| 05/29/2008 | US20080124721 Diagnosing cell proliferative disorders via detecting and enhancing concentration of cancer cells present in peripheral blood |
| 05/29/2008 | US20080124720 Method Of Sample Analysis And Apparatus Therefor |
| 05/29/2008 | US20080124711 Protocol for detecting proteins in a culture containing an embryo |
| 05/29/2008 | US20080124709 Nucleic acid size detection method |
| 05/29/2008 | US20080124702 Methods of diagnosing cervical cancer |
| 05/29/2008 | US20080124434 Custom Food Product Preparation Methods And Apparatus |
| 05/29/2008 | US20080124433 laser that creates small holes in a food item with an output beam, includes a post processing module that enables a substance may include a flavoring, a vitamin, a medicine, a gas, steam, and the like to pass through the holes; holes facilitate cooking, cleaning, flavorizing, medicating |
| 05/29/2008 | US20080124380 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier |
| 05/29/2008 | US20080124362 Domain II Mutants Of Anthrax Lethal Factor |
| 05/29/2008 | US20080124353 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124351 Proteinase k resistant surface protein of neisseria meningitidis |
| 05/29/2008 | US20080124345 Human epidermal growth factor (HER) binding ligand for use in prevention and treatment of cell proliferative disorders |
| 05/29/2008 | US20080124339 Monoclonal antibody specific to mucosal addressin cell adhesion molecule (MAdCAM) for use in prevention and treatment of inflammatory, gastrointestinal, liver disorders |
| 05/29/2008 | US20080124337 Immunoglobulin for use in diagnosis, prevention and treatment of neisserial infection; immunootherapeutics |
| 05/29/2008 | US20080124336 Molecules and Methods for Inhibiting Shedding of KIM-1 |
| 05/29/2008 | US20080124335 Novel Polypeptide and the Use Thereof |
| 05/29/2008 | US20080124334 Isolated Nucleic Acids, Vectors and Host Cells Encoding ErbB3 Antibodies |
| 05/29/2008 | US20080124331 Compositions and methods for the diagnosis and treatment of tumor |
| 05/29/2008 | US20080124329 Conditioned Cell Immunization |
| 05/29/2008 | US20080124327 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 05/29/2008 | US20080124317 Diagnos and Treatment of Fibrosis Related Pathology |
| 05/29/2008 | US20080124313 Nucleotide sequences coding methionyl tRNA synthetase protein for use in identifying modulators for prevention and treatment of bacterial infection |
| 05/29/2008 | US20080124310 Bead based receptor biology |
| 05/29/2008 | US20080124309 Cell Surface Glycoprotein |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | US20080124274 Compositions and methods for detecting and treating tumors containing acidic areas |
| 05/29/2008 | US20080123089 Quality control method for making a biochip displaying an encoded bead array |
| 05/29/2008 | US20080121012 Electrode Calibration |
| 05/29/2008 | DE202008004429U1 Einrichtung zur Überprüfung von Getreidekorn Means for checking of cereal grain |
| 05/29/2008 | DE202008000834U1 Zusammensetzung und Reagenz für CTLA-4 und Verwendungen derselben Composition and reagent for CTLA-4 and uses thereof |
| 05/29/2008 | DE10256009B4 Verfahren und Vorrichtung zur Bereitstellung einer gasförmigen Substanz für die Analyse von chemischen Elementen oder Verbindungen A method and apparatus for providing a gaseous substance for the analysis of chemical elements or compounds |
| 05/29/2008 | DE102007041813A1 Neoplasie-spezifische tNOX-Isoformen und Verfahren Neoplasia-specific tNOX isoforms and methods |
| 05/29/2008 | DE102007031234A1 Biosensor-Teststreifen mit Nichtenzym-Harnsäure-Reagenz, dessen Meßvorrichtung und Herstellungsverfahren Biosensor test strip with a non-enzymatic uric acid reagent, the measuring apparatus and manufacturing processes |
| 05/29/2008 | DE102007031232A1 Bio sensor test strip for measuring blood sugar concentration of patient, has capillary channel with ends possessing zone and hole in direction, where channel is formed by thickness and form of glue layer |
| 05/29/2008 | DE102006056540A1 Vorrichtung und Verfahren zur Untersuchung von biologischen und medizinischen Proben Apparatus and method for analyzing biological and medical samples |
| 05/29/2008 | DE102006055990A1 Vorrichtung und Verfahren zur Messung biologischer und elektronischer Eigenschaften einer Probe Apparatus and method for measuring biological and electronic properties of a sample |
| 05/29/2008 | DE102006055358A1 Quantitative comparison process for two or more proteins involves reductive alkylizing with keton in presence of hydrating reagent |
| 05/29/2008 | DE102006054909A1 Fuel oil composition, useful as mineral diesels, comprises fuel oil, palmitic- and stearic acid methylester, copolymer containing vinylester and ethylene, comb-polymer containing olefin and ethylenically unsaturated dicarboxylic acid |
| 05/29/2008 | CA2683114A1 Cells expressing alpha-synuclein and uses therefor |
| 05/29/2008 | CA2670443A1 Method for predicting the response to a therapy |
| 05/29/2008 | CA2670265A1 Blood glucose meter capable of wireless communication |
| 05/29/2008 | CA2669879A1 Ion sensor for fluid and method for its manufacture |
| 05/29/2008 | CA2669602A1 Anti-idiotype conjugate and its use as a standard in an immunassay |
| 05/29/2008 | CA2669275A1 Agent for inhibiting cytokinin signaling |
| 05/29/2008 | CA2669194A1 Methodologies, processes and automated devices for the orientation, sampling and collection of seed tissues from individual seed |
| 05/29/2008 | CA2669191A1 Apparatus, method and system for handling, positioning, and/or automatically orienting objects |
| 05/29/2008 | CA2669092A1 Method for the sequential analysis of different components in a single biological sample and reagents therefor |
| 05/29/2008 | CA2668773A1 Therapeutic targeting of escort proteins |
| 05/29/2008 | CA2667771A1 Method and apparatus for enhanced bacteriophage-based diagnostic assays by selective inhibition of potential cross reactive organisms |
| 05/29/2008 | CA2667357A1 Proteomic analysis of biological fluids |
| 05/29/2008 | CA2666234A1 Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| 05/29/2008 | CA2665536A1 Multifunctional encoded particles for high-throughput analysis |
| 05/29/2008 | CA2661661A1 Intermediates and methods for forming passivated surfaces on oxide layers and articles produced thereby |
| 05/28/2008 | EP1925943A1 Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of Troponin T and NT-proBNP. |
| 05/28/2008 | EP1925942A1 Method for diagnosing diabetes mellitus |
| 05/28/2008 | EP1925941A1 Method for prediction of the efficacy of vascularization inhibitor |
| 05/28/2008 | EP1925940A1 Circulating ve-cadherin as a predictive marker of sensitivity or resistance to anti-tumoral treatment, and improved method for the detection of soluble proteins |
| 05/28/2008 | EP1925939A1 Antibody-sensitized latex |
| 05/28/2008 | EP1925938A1 Method for determining the effect of a test agent on a target molecule |
| 05/28/2008 | EP1925937A1 Method for assaying antigen related to disorders caused by mental stress |